Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

113.78
Delayed Data
As of Feb 12
 +1.06 / +0.94%
Today’s Change
108.50
Today|||52-Week Range
194.73
-19.05%
Year-to-Date

Today’s Trading

Previous close112.72
Today’s open113.05
Day’s range109.44 - 115.75
Volume592,017
Average volume (3 months)696,173
Market cap$7.0B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-73.50%
Earnings growth (this year)+12.92%
Earnings growth (next 5 years)+13.00%
Revenue growth (last year)+34.44%
P/E ratio22.6
Price/Sales8.74
Price/Book5.03

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+1.83+3.02%
RDYDr.Reddy's Laborator...-0.42-0.99%
IDXXIDEXX Laboratories I...+0.58+0.86%
UTHRUnited Therapeutics ...+4.95+4.07%
Data as of 4:01pm ET, 02/12/2016

Financials

Next reporting dateFebruary 24, 2016
EPS forecast (this quarter)$2.60
Annual revenue (last year)$1.2B
Annual profit (last year)$58.4M
Net profit margin4.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers